HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Jakubowski Selected Research

homocysteine thiolactone

1/2021Copper, heart disease and homocysteine thiolactone.
1/2019Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial.
12/2008The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
12/2004Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
10/2001Protein N-homocysteinylation: implications for atherosclerosis.
2/2001Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
7/2000Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis.
2/2000Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Jakubowski Research Topics

Disease

10Atherosclerosis
12/2008 - 02/2000
4Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 02/2001
3Myocardial Infarction
01/2019 - 12/2004
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2019 - 12/2004
2Hypertension (High Blood Pressure)
01/2019 - 07/2008
2Stroke (Strokes)
07/2008 - 01/2007
1Heart Diseases (Heart Disease)
01/2021
1Thrombosis (Thrombus)
12/2008
1Homocystinuria
12/2008
1Vascular Diseases (Vascular Disease)
12/2008
1Hyperhomocysteinemia
12/2008
1Necrosis
07/2008
1Inflammation (Inflammations)
07/2008
1Obesity
07/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2007
1Coronary Disease (Coronary Heart Disease)
12/2006

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
12/2008 - 02/2000
8homocysteine thiolactoneIBA
01/2021 - 02/2000
8HomocysteineIBA
01/2019 - 02/2001
3Aryldialkylphosphatase (Paraoxonase)IBA
12/2006 - 02/2000
1CopperIBA
01/2021
1KynurenineIBA
01/2019
1PyridoxalIBA
01/2019
1Methionine-tRNA LigaseIBA
01/2019
1PotassiumIBA
01/2019
1CreatinineIBA
01/2019
1BilirubinIBA
01/2019
1Vitamin B Complex (B Vitamins)IBA
01/2019
1AntibodiesIBA
12/2008
1Apolipoproteins E (ApoE)IBA
12/2008
1Cystathionine beta-Synthase (Serine Sulfhydrase)IBA
12/2008
1Fibrinogen (Factor I)FDA Link
12/2008
1Methionine (L-Methionine)FDA Link
12/2008
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
12/2008
1LipidsIBA
07/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008
1Interleukin-6 (Interleukin 6)IBA
07/2008
1Amino AcidsFDA Link
01/2007
1Transfer RNA (tRNA)IBA
11/2001
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2001
1Ligases (Synthetase)IBA
11/2001
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2001
1Lysine (L-Lysine)FDA Link
02/2001